Published in Salud Publica Mex on January 01, 2003
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol (2012) 9.28
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis (2007) 6.86
Global burden of human papillomavirus and related diseases. Vaccine (2012) 5.48
Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer (2006) 3.38
Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer (2009) 3.33
Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet (2003) 2.71
Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am J Epidemiol (2003) 1.96
Uses and limitations of statistical accounting for random error correlations, in the validation of dietary questionnaire assessments. Public Health Nutr (2002) 1.94
Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev (2010) 1.85
Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am (2013) 1.74
Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. Eur J Cancer (2013) 1.57
Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study. Am J Epidemiol (2013) 1.48
Multiple human papillomavirus infections: the exception or the rule? J Infect Dis (2011) 1.47
A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology (2013) 1.44
Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy. AIDS (2009) 1.42
The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. PLoS One (2016) 1.40
World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology (2015) 1.38
Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology. Int J Cancer (2010) 1.32
Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica. J Infect Dis (2011) 1.25
Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa. Int J Cancer (2011) 1.23
Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix. Int J Cancer (2008) 1.21
HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4⁺ T-cell lymphocytes. Blood (2011) 1.13
Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study. Eur J Cancer (2011) 1.12
HPV infection in Europe. Eur J Cancer (2009) 1.10
Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer. Int J Cancer (2012) 1.10
Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region. Vaccine (2008) 1.07
Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antivir Ther (2009) 1.04
Burden and trends of type-specific human papillomavirus infections and related diseases in the latin america and Caribbean region. Vaccine (2008) 1.03
International correlation between human papillomavirus prevalence and cervical cancer incidence. Cancer Epidemiol Biomarkers Prev (2008) 1.02
Clustering of human papillomavirus (HPV) types in the male genital tract: the HPV in men (HIM) study. J Infect Dis (2011) 1.01
EUROGIN 2008 roadmap on cervical cancer prevention. Int J Cancer (2009) 1.00
Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela. Cancer Epidemiol Biomarkers Prev (2004) 0.99
Dried blood spot samples for seroepidemiology of infections with human papillomaviruses, Helicobacter pylori, Hepatitis C Virus, and JC Virus. Cancer Epidemiol Biomarkers Prev (2011) 0.98
Polymorphisms in genes related to bacterial lipopolysaccharide/peptidoglycan signaling and gastric precancerous lesions in a population at high risk for gastric cancer. Dig Dis Sci (2006) 0.97
Human papillomavirus vaccines and anal carcinoma. Curr Opin HIV AIDS (2009) 0.95
Genetic variation in PSCA and risk of gastric advanced preneoplastic lesions and cancer in relation to Helicobacter pylori infection. PLoS One (2013) 0.94
Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer. Int J Cancer (2014) 0.92
Prevalence of cervical human papillomavirus (HPV) infection in Vanuatu. Cancer Prev Res (Phila) (2012) 0.92
Variations in Helicobacter pylori cytotoxin-associated genes and their influence in progression to gastric cancer: implications for prevention. PLoS One (2012) 0.92
Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. J Natl Cancer Inst (2014) 0.90
Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Lancet Oncol (2013) 0.89
Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study. Cancer Epidemiol Biomarkers Prev (2011) 0.88
Genetic polymorphisms in mediators of inflammation and gastric precancerous lesions. Eur J Cancer Prev (2008) 0.88
Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status. Int J Cancer (2013) 0.88
Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study. Int J Cancer (2015) 0.87
Human Papillomavirus Vaccination of Boys and Extended Catch-up Vaccination: Effects on the Resilience of Programs. J Infect Dis (2015) 0.87
Comparison of polymerase chain reaction and histopathology for the detection of Helicobacter pylori in gastric biopsies. Int J Cancer (2010) 0.86
Genetic polymorphisms in anti-inflammatory cytokine signaling and the prevalence of gastric precancerous lesions in Venezuela. Cancer Causes Control (2006) 0.85
Effect of HIV Infection on Human Papillomavirus Types Causing Invasive Cervical Cancer in Africa. J Acquir Immune Defic Syndr (2016) 0.84
Human Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide. J Virol (2015) 0.84
Patterns of human papillomavirus types in multiple infections: an analysis in women and men of the high throughput human papillomavirus monitoring study. PLoS One (2013) 0.83
Naturally acquired immunity against human papillomavirus (HPV): why it matters in the HPV vaccine era. J Infect Dis (2014) 0.83
Host-bacterial interaction in the development of gastric precancerous lesions in a high risk population for gastric cancer in Venezuela. Int J Cancer (2006) 0.83
Clustering patterns of human papillomavirus infections among HIV-positive women in Kenya. Infect Agent Cancer (2013) 0.83
Racial disparities in Human Papillomavirus (HPV) associated head and neck cancer. Am J Otolaryngol (2013) 0.82
Cancers attributable to infections among adults with HIV in the United States. AIDS (2015) 0.82
Genome-wide association study of HPV seropositivity. Hum Mol Genet (2011) 0.82
Type-specific human papillomavirus biological features: validated model-based estimates. PLoS One (2013) 0.82
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice. Int J Cancer (2017) 0.82
Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study. Lancet Oncol (2016) 0.82
Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer (2017) 0.80
Methylation Levels of CADM1, MAL, and MIR124-2 in Cervical Scrapes for Triage of HIV-Infected, High-Risk HPV-Positive Women in Kenya. J Acquir Immune Defic Syndr (2015) 0.80
Commentary: An OPEN assessment of dietary measurement errors. Int J Epidemiol (2003) 0.80
Use of whole genome amplification to rescue DNA from plasma samples. Biotechniques (2005) 0.79
Residual disease and HPV persistence after cryotherapy for cervical intraepithelial neoplasia grade 2/3 in HIV-positive women in Kenya. PLoS One (2014) 0.79
Prevalence of HPV infection and other risk factors in a Fijian population. Infect Agent Cancer (2014) 0.78
Comparison of Two Widely Used Human Papillomavirus Detection and Genotyping Methods, GP5+/6+-Based PCR Followed by Reverse Line Blot Hybridization and Multiplex Type-Specific E7-Based PCR. J Clin Microbiol (2016) 0.78
Helicobacter pylori and colonic neoplasms. Am J Gastroenterol (2013) 0.77
Baseline and lifetime alcohol consumption and risk of differentiated thyroid carcinoma in the EPIC study. Br J Cancer (2015) 0.77
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia. Clin Infect Dis (2016) 0.77
Embryonic cells in the squamous-columnar junction of the cervix: scope for prophylactic ablation? Int J Cancer (2014) 0.76
Hepatitis C Virus Seroprevalence in Mongolian Women Assessed by a Novel Multiplex Antibody Detection Assay. Cancer Epidemiol Biomarkers Prev (2015) 0.76
Infection with hepatitis viruses, FIB-4 index and risk of hepatocellular carcinoma in southern Italy: a population-based cohort study. Infect Agent Cancer (2016) 0.75
Low frequency of cigarette smoking and the risk of head and neck cancer in the INHANCE consortium pooled analysis. Int J Epidemiol (2015) 0.75
Clifford et al. respond to "Biological and clinical insights from epidemiologic research into HIV, HPV, and anal cancer". Am J Epidemiol (2013) 0.75
Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer. Clin Infect Dis (2017) 0.75
β- and γ-Human Papillomavirus Types and Smoking in Head and Neck Cancer. JAMA Oncol (2016) 0.75
HPV-associated differential regulation of tumor metabolism in oropharyngeal head and neck cancer. Oncotarget (2017) 0.75
HPV-associated differential regulation of tumor metabolism in oropharyngeal head and neck cancer. Oncotarget (2017) 0.75
Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study. J Infect Dis (2017) 0.75
Immuno-related polymorphisms and cervical cancer risk: The IARC multicentric case-control study. PLoS One (2017) 0.75
Cervical screening: toward an equal risk/equal management approach, irrespective of HIV status. AIDS (2017) 0.75
Consumption of Fish Is Not Associated with Risk of Differentiated Thyroid Carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. J Nutr (2017) 0.75
Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in Bhutan. Oncotarget (2017) 0.75